Astrazeneca ploughs £300m into UK in surprise U-turn

City AM — Apr 29, 15:28 PM

Astrazeneca had previously axed a £200m expansion over the UK's drug pricing https://www.cityam.com/wp-content/uploads/2024/05/astrazeneca-covid-treatment-57611043-1.webp?w=1107" />

British drugs giant Astrazeneca has promised to plough £300m into its UK operations, just months after cancelling a nine-figure investment in a new lab after getting in a spat with the UK government over drug pricing.

In a stunning volte-face, the UK’s largest pharmaceutical company said it would revive its £200m investment into a megalab https://www.cityam.com/astrazeneca-to-plough-300m-into-uk-operations/">[...]

Read full article at City AM →

AstraZeneca beats expectations

UK's biggest drugmakers see surprise profit bump, even as pharma grapples with U.S. policies CNBC — Apr 29, 09:32 AM
Astrazeneca tops expectations in the first quarter on strong cancer drug sales Associated Press — Apr 29, 12:06 PM
AstraZeneca posted stronger-than-expected profit and revenue on surging cancer drug sales Quartz — Apr 29, 12:00 PM
AstraZeneca makes surprise U-turn with £300m pharma investment The Guardian — Apr 29, 12:15 PM
Shot in the arm for GSK and AstraZeneca from cancer drug sales The Argus — Apr 29, 11:25 AM